The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
JOSEPH, Immanual, TRESSLER, Robert, BASSETT, Ekaterina, HARLEY, Calvin, BUSEMAN, Christen M, PATTAMATTA, Preeti, WRIGHT, Woodring E, SHAY, Jerry W, GO, Ning F
Published in Cancer research (Chicago, Ill.) (15.11.2010)
Published in Cancer research (Chicago, Ill.) (15.11.2010)
Get full text
Journal Article
An mre11 mutation that promotes telomere recombination and an efficient bypass of senescence
Joseph, Immanual S, Kumari, Alpana, Bhattacharyya, Mrinal K, Gao, Honghai, Li, Bibo, Lustig, Arthur J
Published in Genetics (Austin) (01.07.2010)
Published in Genetics (Austin) (01.07.2010)
Get full text
Journal Article
Abstract A56: The telomerase inhibitor imetelstat exhibits antitumor and anticancer stem cell effects through perturbation of casein kinase-2 signaling
Nitta, Ryan T., O'Sullivan, Christopher, Ramiya, Amrita, Lin, Tong, Kashani, Hooman, Joseph, Immanual S.
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Abstract 4291: Imetelstat, a telomerase inhibitor in phase I trials in solid tumor and hematological malignancies, has broad activity against multiple types of cancer stem cells
Joseph, Immanual, Matsui, William, LaPorta, Caterina A M, Tabori, Uri, Kornblum, Harley, Herbert, Brittney-Shea, Harley, Calvin, Tressler, Robert J.
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article